Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
This study is ongoing, but not recruiting participants.
Study NCT00010452   Information provided by FDA Office of Orphan Products Development
First Received: February 2, 2001   Last Updated: March 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphatic Malformations
Additional conditions recognized in this trial
Congenital Abnormalities
Lymphangioma, Cystic
Lymphatic Abnormalities
More general conditions related to this trial
Lymphangioma
Lymphatic Diseases
Lymphatic Vessel Tumors
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
picibanil
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Iowa
Chugai Pharmaceutical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services